|
Mobile version
|
||||||||||||||||||||||||||||||||||
Business analytics: Turning intellectual property into opportunity CIO Insight Share     North Carolina State University had a challenge. It needed a new process to monetize its treasure trove of scientific advancements and university-invented technologies by matching these with potential research partners and sponsors. Any organization sitting on reams of intellectual property will learn from the experiences of Billy Houghteling, Director of the Office of Technology Transfer at North Carolina State University. His office is responsible for transferring University-developed innovations to the marketplace and interacting with partners. "Our portfolio is very large, very diverse and it's understaffed," says Houghteling. "We have a hard time managing the intellectual property assets we have." More
Mayo's 'smart' adult stem cells repair hearts - 'Landmark work' moves beyond the bench Mayo Clinic via Disabled World Share
Mayo Clinic investigators, with Belgian collaborators, have demonstrated that rationally "guided" human adult stem cells can effectively heal, repair and regenerate damaged heart tissue. The findings &mdash called "landmark work" in an accompanying editorial — appear in the Journal of the American College of Cardiology. More Industries should look beyond ownership of intellectual property Indian Express Share
For the proper exploitation of academic research, many universities in the United Kingdom have tried to come out with a model where the industry and educational institutions work closely to take research to the level of making it commercially applicable as also look beyond intellectual property rights issues. Professor Sir William Wakeham, vice-chancellor, University of Southampton in the United Kingdom, spoke at length on this concept at the Indian Institute of Science Education and Research. Wakeham's lecture was part of the nationwide lecture series being organised jointly by the British High Commission and the Indian Institute of Science, to mark its centenary year. More Stimulating science The Chicago Sun-Times Share
Nicole Tuttle, a University of Chicago student earning her doctorate in chemistry, is conducting the kind of pure research most corporations gave up a decade ago and which local academic institutions are seeking to commercialize faster than ever before. In Chicago's case, the research won't lead to any immediate commercial gadgets or medical treatments; indeed, the work could take decades to reveal its best uses. More
Commercialization: Promises, challenges Northern Nevada Business Weekly Share
Whether its medical research at the University of Nevada, Reno, School of Medicine or renewable energy research at Desert Research Institute, Mike Skaggs says work in the Nevada laboratories increasingly will be mined to create new jobs. The message is getting to researchers at universities and laboratories. "It's a big push here," says Alan Gertler, a research professor and executive director of Clean Technologies and Renewable Energy Center at DRI. No one thinks that widespread commercialization of research from Nevada laboratories will be either easy or quick. More In their element: The science of science The Independent Share
Scientists have been examining their own careers for centuries, but only relatively recently as a separate field of research. This intellectual analysis, called "scientometrics," emerged in the 1960s, and is essentially the "science of science." It posits questions such as, "How is productivity changing?" or "How many researchers do we need?" and now, "Are scientific discoveries getting more difficult?" More Cryo-Cell announces C'elle (sm) research and development collaboration with department of medicine, Monash University in Australia GlobeNewswire via Market Watch Share
Cryo-Cell International, one of the largest and most established leaders in stem cell innovation, announced a research and development collaboration agreement with Monash University in Australia. The partnership will allow scientists from the University's Centre of Inflammatory Diseases to conduct pre-clinical studies using Cryo-Cell's proprietary C'elle (sm) menstrual stem cell technology to identify potential future therapies to treat autoimmune diseases such as multiple sclerosis. More DreamWorks, Blizzard, SABC, Utz, FirstRand, WTO: Intellectual property Bloomberg Share
Intellectual Ventures, which is headed by former Microsoft Chief Technology Officer Nathan Myhrvold, is a closely held company with a large patent portfolio across broad technology lines. The company has acquired large numbers of patents from individual inventors and universities, and has licensed many of them to companies that might have potentially infringed the patents. More |
|
|||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
